A meta-analysis of microrna expression in liver cancer

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Yang, Jingcheng ^a   Han, Shuai ^a   Huang, Wenwen ^a   Chen, Ting ^b   Liu, Yang ^a   Pan, Shangling ^c   Li, Shikang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI TEACHERS EDUCATION UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 130A; MICRORNA 195; MICRORNA 199A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 224; MICRORNA 375; MICRORNA 93; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT CARCINOMA; CLUSTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; HEPATOBLASTOMA; LIVER CANCER; LIVER CELL CARCINOMA; MUTATIONAL ANALYSIS; PATHOGENESIS; SIGNAL TRANSDUCTION; UPREGULATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LIVER TUMOR; META ANALYSIS;

CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MICRORNAS;

EID: 84916596972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114533     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Giordano S, Columbano A (2013) MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 57: 840-847.
3. Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482: 347-355.
4. Borel F, Konstantinova P, Jansen PL (2012) Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol 56: 1371-1383.
5. Kolde R, Laur S, Adler P, Vilo J (2012) Robust rank aggregation for gene list integration and metaanalysis. Bioinformatics 28: 573-580.
6. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
7. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847.
8. Maragkakis M, Alexiou P, Papadopoulos GL, Reczko M, Dalamagas T, et al. (2009) Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 10: 295.
9. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-229.
10. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, et al. (2011) starBase: a database for exploring microRNAmRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39: D202-209.
11. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, et al. (2009) GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 37: W317-322.
12. Noh JH, Chang YG, Kim MG, Jung KH, Kim JK, et al. (2013) MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 335: 455-462.
13. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, et al. (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4: e8003.
14. Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, et al. (2010) microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 6: 402.
15. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, et al. (2012) Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56: 1792-1803.
16. Wallden B, Emond M, Swift ME, Disis ML, Swisshelm K (2005) Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells. BMC Cancer 5: 140.
17. Diaz G, Melis M, Tice A, Kleiner DE, Mishra L, et al. (2013) Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma. Int J Cancer 133: 816-824.
18. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, et al. (2013) Meta-analysis of microRNA expression in lung cancer. Int J Cancer 132: 2884-2893.
19. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, et al. (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661.
20. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, et al. (2009) MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081.
21. Park JK, Kogure T, Nuovo GJ, Jiang J, He L, et al. (2011) miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 71: 7608-7616.
22. Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, et al. (2012) Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 56: 1025-1033.
23. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, et al. (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107: 264-269.
24. Li J, Wang Y, Yu W, Chen J, Luo J (2011) Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem Biophys Res Commun 406: 70-73.
25. He XX, Guo AY, Xu CR, Chang Y, Xiang GY, et al. (2014) Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncol Rep 32: 1200-1210.
26. Wong QW, Ching AK, Chan AW, Choy KW, To KF, et al. (2010) MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 16: 867-875.
27. Bao L, Yan Y, Xu C, Ji W, Shen S, et al. (2013) MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett 337: 226-236.
28. Ma D, Tao X, Gao F, Fan C, Wu D (2012) miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett 4: 483-488.
29. Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, et al. (2014) Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer 14: 721.
30. Li Q, Ding C, Chen C, Zhang Z, Xiao H, et al. (2014) miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma. J Gastroenterol Hepatol 29: 835-842.
31. Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, et al. (2013) Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol 28: 565-575.
32. Yu L, Zhang J, Guo X, Li Z, Zhang P (2014) MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. Cancer Epidemiol 38: 408-413.
33. Yang X, Yu J, Yin J, Xiang Q, Tang H, et al. (2012) MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. Pharmazie 67: 645-651.
34. Ding J, Huang S, Wang Y, Tian Q, Zha R, et al. (2013) Genome-wide screening reveals that miR-195 targets the TNF-alpha/NF-kappaB pathway by down-regulating IkappaB kinase alpha and TAB3 in hepatocellular carcinoma. Hepatology 58: 654-666.
35. Wang R, Zhao N, Li S, Fang JH, Chen MX, et al. (2013) MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 58: 642-653.
36. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, et al. (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121.
37. Chang Y, Yan W, He X, Zhang L, Li C, et al. (2012) miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 143: 177-187.e178.
38. He XX, Chang Y, Meng FY, Wang MY, Xie QH, et al. (2012) MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31: 3357-3369.
39. Amer M, Elhefnawi M, El-Ahwany E, Awad AF, Gawad NA, et al. (2014) Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span. Tumour Biol: ahead of print.
40. Jiang HL, Yu H, Ma X, Xu D, Lin GF, et al. (2014) MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells. Tumour Biol 35: 6955-6960.
41. Cairo S, Wang Y, de Reynies A, Duroure K, Dahan J, et al. (2010) Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 107: 20471-20476.
42. Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, et al. (2010) High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep 23: 113-119.
43. Elyakim E, Sitbon E, Faerman A, Tabak S, Montia E, et al. (2010) hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res 70: 8077-8087.
44. Koh YS, Kim JH, Cai H, Li LH, Kim HS, et al. (2013) Dysregulated microRNAs in non-cirrhotic hepatocellular carcinoma. Genes & Genomics 35: 759-765.
45. Li W, Xie L, He X, Li J, Tu K, et al. (2008) Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 123: 1616-1622.
46. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
47. Sato F, Hatano E, Kitamura K, Myomoto A, Fujiwara T, et al. (2011) MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One 6: e16435.
48. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, et al. (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49: 1595-1601.
49. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, et al. (2012) MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 57: 584-591.
50. Su H, Yang JR, Xu T, Huang J, Xu L, et al. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142.
51. Yang L, Ma Z, Wang D, Zhao W, Chen L, et al. (2010) MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol Ther 9: 803-808.